Institut Pasteur exploits its research results through an aggressive technology transfer program towards industry. Two thirds of its research units have already generated a substantial patent portfolio that is now available for licensing to industry. Through licensing agreements, companies have had access to the greatest discoveries made at Institut Pasteur. Several have resulted in major products that tremendously contributed to improve human health; Diagnostic kits for AIDS and the vaccine against Hepatitis B are among the most well-known.
The Office of Technology Transfer is responsible for managing assigned inventions/ technologies resulting from research conducted at Institut Pasteur. Many of these inventions have been patented. The list below provides links to non-confidential descriptions and information including availability for licensing for a wide variety of Institut Pasteur technologies. This list will be updated on a regular basis.